These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 9421496)

  • 1. Zwitterionic oligodeoxyribonucleotide N3'-->P5' phosphoramidates: synthesis and properties.
    Mignet N; Gryaznov SM
    Nucleic Acids Res; 1998 Jan; 26(2):431-8. PubMed ID: 9421496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. alpha-Oligodeoxyribonucleotide N3'-->P5' phosphoramidates: synthesis and duplex formation.
    Pongracz K; Gryaznov SM
    Nucleic Acids Res; 1998 Feb; 26(4):1099-106. PubMed ID: 9461474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oligonucleotide n3'-->p5' phosphoramidates and thio-phoshoramidates as potential therapeutic agents.
    Gryaznov SM
    Chem Biodivers; 2010 Mar; 7(3):477-93. PubMed ID: 20232321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA mimetics: oligoribonucleotide N3'-->P5' phosphoramidates.
    Gryaznov SM; Winter H
    Nucleic Acids Res; 1998 Sep; 26(18):4160-7. PubMed ID: 9722635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of oligodeoxyribonucleotide N3'-->P5' phosphoramidates.
    Chen JK; Schultz RG; Lloyd DH; Gryaznov SM
    Nucleic Acids Res; 1995 Jul; 23(14):2661-8. PubMed ID: 7651827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and properties of RNA analogs-oligoribonucleotide N3'-->P5' phosphoramidates.
    Matray TJ; Gryaznov SM
    Nucleic Acids Res; 1999 Oct; 27(20):3976-85. PubMed ID: 10497261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oligonucleotide N3'-->P5' phosphoramidates as potential therapeutic agents.
    Gryaznov SM
    Biochim Biophys Acta; 1999 Dec; 1489(1):131-40. PubMed ID: 10807003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligonucleotide N3'-->P5' phosphoramidates.
    Gryaznov SM; Lloyd DH; Chen JK; Schultz RG; DeDionisio LA; Ratmeyer L; Wilson WD
    Proc Natl Acad Sci U S A; 1995 Jun; 92(13):5798-802. PubMed ID: 7541136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oligodeoxynucleoside phosphoramidates (P-NH2): synthesis and thermal stability of duplexes with DNA and RNA targets.
    Peyrottes S; Vasseur JJ; Imbach JL; Rayner B
    Nucleic Acids Res; 1996 May; 24(10):1841-8. PubMed ID: 8657564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oligo-2'-fluoro-2'-deoxynucleotide N3'-->P5' phosphoramidates: synthesis and properties.
    Schultz RG; Gryaznov SM
    Nucleic Acids Res; 1996 Aug; 24(15):2966-73. PubMed ID: 8760881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNase H-independent antisense activity of oligonucleotide N3 '--> P5 ' phosphoramidates.
    Heidenreich O; Gryaznov S; Nerenberg M
    Nucleic Acids Res; 1997 Feb; 25(4):776-80. PubMed ID: 9016628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and purification of oligonucleotide N3'-->P5' phosphoramidates and their phosphodiester and phosphorothioate chimeras.
    Fearon KL; Nelson JS
    Curr Protoc Nucleic Acid Chem; 2001 May; Chapter 4():Unit 4.7. PubMed ID: 18428854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oligonucleotide N3'-->P5' phosphoramidates as efficient telomerase inhibitors.
    Herbert BS; Pongracz K; Shay JW; Gryaznov SM
    Oncogene; 2002 Jan; 21(4):638-42. PubMed ID: 11850790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and properties of 3'-amino-2',4'-BNA, a bridged nucleic acid with a N3'-->P5' phosphoramidate linkage.
    Obika S; Rahman SM; Song B; Onoda M; Koizumi M; Morita K; Imanishi T
    Bioorg Med Chem; 2008 Oct; 16(20):9230-7. PubMed ID: 18812260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of a ribonuclease H digestion of N3'-->P5' phosphoramidate-RNA duplexes by capillary gel electrophoresis.
    DeDionisio L; Gryaznov SM
    J Chromatogr B Biomed Appl; 1995 Jul; 669(1):125-31. PubMed ID: 7581876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The detection of oligonucleotide N3'-->P5' phosphoramidate/RNA duplexes with capillary gel electrophoresis.
    DeDionisio L; Raible AM; Gryaznov SM
    Electrophoresis; 1998 Jun; 19(8-9):1265-9. PubMed ID: 9694262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural RNA mimetics: N3'-->P5' phosphoramidate DNA analogs of HIV-1 RRE and TAR RNA form A-type helices that bind specifically to Rev and Tat-related peptides.
    Rigl CT; Lloyd DH; Tsou DS; Gryaznov SM; Wilson WD
    Biochemistry; 1997 Jan; 36(3):650-9. PubMed ID: 9012680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic oligonucleotides as RNA mimetics: 2'-modified Rnas and N3'-->P5' phosphoramidates.
    Egli M; Gryaznov SM
    Cell Mol Life Sci; 2000 Sep; 57(10):1440-56. PubMed ID: 11078022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of IL-6 in mice by anti-NF-kappaB oligodeoxyribonucleotide N3'-->oligodeoxyribonnucleotide N3' --> P5' phosphoramidates.
    Wang L; Gryaznov S; Nerenberg M
    Inflammation; 1999 Dec; 23(6):583-90. PubMed ID: 10565571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Oligonucleotide 2'-O-Alkyl N3'→P5' (Thio)-Phosphoramidates as Potent Antisense Agents: Physicochemical Properties and Biological Activity.
    Martínez-Montero S; Rajwanshi VK; Pandey RK; De Costa NTS; Hong J; Beigelman L; Gryaznov SM; Pourshahian S
    Nucleic Acid Ther; 2023 Oct; 33(5):319-328. PubMed ID: 37638793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.